Gentao Liu
Maxine Dunitz Neurosurgical Institute
Cedars-Sinai Medical Center
Los Angeles
California
USA
Name/email consistency: high
- Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination. Liu, G., Black, K.L., Yu, J.S. Expert. Rev. Vaccines (2006)
- Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I.R., Lu, L., Irvin, D., Black, K.L., Yu, J.S. Mol. Cancer (2006)
- AIM-2: a novel tumor antigen is expressed and presented by human glioma cells. Liu, G., Yu, J.S., Zeng, G., Yin, D., Xie, D., Black, K.L., Ying, H. J. Immunother. (2004)
- Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma. Liu, G., Khong, H.T., Wheeler, C.J., Yu, J.S., Black, K.L., Ying, H. J. Immunother. (2003)